Related Experiment Videos
Product-enhanced reverse transcriptase assay for replication-competent retrovirus and lentivirus detection
Lakshmi Sastry1, Yi Xu, Lisa Duffy
1Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Human Gene Therapy
|October 13, 2005
Summary
The product-enhanced reverse transcriptase (PERT) assay effectively detects replication-competent retroviruses (RCR) and lentivirus (RCL) in vectors. This sensitive assay offers a reliable alternative for RCR and RCL testing across diverse retroviral vector types.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- Reverse transcriptase (RT) activity is crucial for retroviral replication.
- Detecting replication-competent retrovirus (RCR) and lentivirus (RCL) is vital for retroviral vector safety.
- Existing RCR and RCL detection methods require rigorous comparison with newer assays.
Purpose of the Study:
- To assess the product-enhanced reverse transcriptase (PERT) assay for RCR and RCL detection in retroviral vectors.
- To compare the PERT assay's sensitivity and reliability against established RCR and RCL detection methods.
Main Methods:
- The PERT assay was used to detect RCR and RCL contaminants in lentiviral and retroviral vectors.
- PERT assay results were compared with p24gag ELISA/gag PCR for RCL detection.
- PERT assay results were compared with the S+/L- assay for RCR detection.
Main Results:
- The PERT assay demonstrated sensitivity comparable to p24gag ELISA and gag PCR for detecting replication-competent HIV-1.
- Both the PERT assay and the extended S+/L- assay detected 1 IU of replication-competent GALV and RD114 viruses.
- The PERT assay proved effective for RCR and RCL testing across various retroviral vector types.
Conclusions:
- The PERT assay is a sensitive and reliable method for detecting RCR and RCL in retroviral vectors.
- The PERT assay's performance is consistent across different vector structures, sequences, and envelopes.
- PERT assay offers a versatile tool for ensuring the safety of retroviral vectors used in research and therapy.